Medical Cannabis Bike Tour Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2018
NCT03529448
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Medical Cannabis Bike Tour

Active Ingredients

Drugs in Phase 2 Trials (3)

cannabidiol (Epidiolex) (1 trial)

temozolomide (temodar) (1 trial)

tetrahydrocannabinol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glioblastoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3